Harshitha Dudipala | Cancer Genetics | Research Excellence Award

Published on by Genetics and Genomics

Dr. Harshitha Dudipala | Cancer Genetics | Research Excellence Award

University of California San Diego | United States

Dr. Harshitha R. Dudipala, MD, is a board-certified physician in Internal Medicine and a highly accomplished Hematology & Oncology Fellow at the University of California, San Diego (Moores Cancer Center), with fellowship completion expected. She completed her Internal Medicine residency at Boston University Medical Center and earned her MD from Northeast Ohio Medical University, following a BS in Natural Sciences from the University of Akron. Dr. Dudipala has an extensive research portfolio spanning genitourinary oncology, lung cancer, immunotherapy biomarkers, molecular profiling, health disparities, and quality improvement, with multiple peer-reviewed publications in high-impact journals and presentations at ASCO, EACR, AAMC, and AMA. Her work has been featured in ASCO Daily News, and she has received numerous honors, including the Alice Jacobs Citizenship Award. An active leader and educator, she holds key roles in fellowship wellness, women in medicine, medical education, advocacy, and community health, reflecting a career dedicated to academic excellence, equity in cancer care, and physician leadership.

Citation Metrics (Scopus)

40
30
20
10
  0

Citations
25

Documents
9

h-index
4

Citations

Documents

h-index


View Scopus Profile
 View Orcid Profile

Featured Publications

Helala AlShehri | Cancer Genetics | Research Excellence Award

Published on by Genetics and Genomics

Assist. Prof. Dr. Helala AlShehri | Cancer Genetics | Research Excellence Award

Jubail Industrial College | Saudi Arabia

Assist. Prof. Dr. Helala Mohammad AlShehri is an Assistant Professor of Computer Science and Deputy for Planning and Development at Jubail Industrial College, Saudi Arabia. She earned her PhD in Computer Science from King Saud University and brings together strong academic leadership with advanced research expertise in artificial intelligence and deep learning. Dr. AlShehri has held several senior administrative roles, including department chair and head of student and academic affairs, contributing significantly to institutional planning, quality assurance, and academic accreditation. Her research focuses on AI-driven medical image analysis, particularly histopathological image classification for cancer diagnosis, explainable AI, and computer-aided decision support. She has published nine peer-reviewed articles in SCI- and Scopus-indexed journals, with over 140 citations. Dr. AlShehri actively collaborates with national and international researchers and serves as a peer reviewer for leading AI and medical imaging journals.

Citation Metrics (Scopus)

1000
100
10
5
0

Citations
97

Documents
6

h-index
5

Citations

Documents

h-index


View Scopus Profile
 View Orcid Profile View Google Scholar Profile

Featured Publications

Jacob Raber | Cancer Genetics | Research Excellence Award

Published on by Genetics and Genomics

Prof. Jacob Raber | Cancer Genetics | Research Excellence Award

OHSU | United States

Prof. Jacob Raber, Ph.D., is a distinguished Professor with interdisciplinary expertise spanning Behavioral Neuroscience, Neurology, Psychiatry, and Radiation Medicine. He serves as an Affiliated Scientist in the Division of Neuroscience at the Oregon National Primate Research Center (ONPRC), Oregon Health & Science University (OHSU), and holds a courtesy appointment as Professor of Pharmaceutical Sciences at Oregon State University. Dr. Raber earned his BSc in Chemistry and MSc in Pharmacochemistry from the Free University of Amsterdam, where his early research focused on β2-adrenergic receptor desensitization, complemented by training in immunochemistry and Yiddish language and literature. He completed his Ph.D. in Molecular Genetics and Virology at the Weizmann Institute of Science in Israel, investigating interferon-regulated pathways under the mentorship of Dr. Michel Revel. His work integrates molecular genetics with translational neuroscience to advance understanding of brain function and disease.

Citation Metrics (Scopus)

20000
15000
10000
500
0

Citations
15,411

Documents
304

h-index
63

Citations

Documents

h-index


View Scopus Profile
 View Orcid Profile

Featured Publications

Nasrin Samadyar | Cancer Genetics | Research Excellence Award

Published on by Genetics and Genomics

Dr. Nasrin Samadyar | Cancer Genetics | Research Excellence Award

Kermanshah University of Technology, Kermanshah | Iran

Dr. Nasrin Samadyar, born on 17 June 1989 in Karaj, Alborz Province, Iran, is an Iranian applied mathematician specializing in numerical analysis, stochastic differential equations, and meshfree computational methods. She earned her BSc in Applied Mathematics from Kharazmi University, followed by an MSc from Amirkabir University of Technology and a PhD in Applied Mathematics (Numerical Analysis) from Malayer University, where her doctoral research focused on meshfree radial basis function methods for solving stochastic integral equations. She later completed a postdoctoral fellowship in Mathematics at Alzahra University, concentrating on numerical solutions of stochastic differential and partial differential equations. A dedicated educator, she has taught courses such as Numerical Analysis, Linear Optimization, Calculus, and Numerical Linear Algebra. Samadyar has authored numerous high-impact journal publications spanning stochastic integral equations, fractional models, operational matrix methods, wavelet techniques, and meshless approaches, contributing significantly to computational mathematics. She also serves as a reviewer for leading international journals, including the International Journal of Biomathematics, Journal of Computational and Applied Mathematics, Applied Mathematics and Computation, and Soft Computing. A member of Iran's National Elites Foundation, she has supervised graduate research on numerical and stochastic equation-solving techniques and participated in advanced mathematical projects, including implicit meshless methods for fractional stochastic Tricomi-type equations. Proficient in MATLAB, MAPLE, MATHEMATICA, LaTeX, and C++, Samadyar continues to advance research in applied and stochastic mathematics through rigorous analysis, innovative numerical schemes, and interdisciplinary applications.

Profiles: Scopus | Google Scholar

Featured Publications

"A new scheme for solving nonlinear Stratonovich Volterra integral equations via Bernoulli’s approximation, Appl", F. Mirzaee, N. Samadyar, S.F. Hosseini., 2025

"Euler polynomial solutions of nonlinear stochastic Ito-Volterra integral equations, J. Comput. Appl",F. Mirzaee, N. Samadyar, S.F. Hosseini., 2025

"Application of orthonormal Bernstein polynomials to construct a efficient scheme for solving fractional stochastic integro-differential equation, Optik Int. J. Light Electron Opt", F. Mirzaee, N. Samadyar., 2025

"Numerical solution of nonlinear stochastic Ito-Volterra integral equations driven by fractional Brownian motion, Math. Meth. Appl",F. Mirzaee, N. Samadyar., 2025

Xinghua Pan | Next-Generation Sequencing | Research Excellence Award

Published on by Genetics and Genomics

Prof. Xinghua Pan | Next-Generation Sequencing | Research Excellence Award

Macau University of Science and Technology | China

Prof. Xinghua (Victor) Pan, PhD, MD, is a distinguished scholar in single-cell technology, genome medicine, cancer biology, regenerative medicine, and multi-omics bioinformatics, currently serving as a Professor at the Precision Regenerative Medicine Research Centre (PRMRC) in the Medical Science Division of Macau University of Science and Technology (MUST), with a secondary affiliation at the State Key Laboratory of Quality Research in Chinese Medicine. A doctoral supervisor in Biomedical Science and Pharmacy programs at MUST, Dr. Pan previously served as Chairman and Professor of Biochemistry and Molecular Biology at Southern Medical University (SMU), where he founded and led the Guangdong Provincial Key Laboratory of Single Cell Technology and Application and held multiple adjunct roles across major hospitals, universities, and national laboratories. With a career spanning Yale University—where he advanced from Associate Research Scientist to Research Scientist and PI-and leadership positions in molecular genomics companies, Dr. Pan brings decades of expertise shaped by rigorous training at Southern Medical University, Fudan University, CAMS & PUMC, and Yale University, complemented by international fellowships at Peking University, Melbourne University, the Ludwig Institute, and Cold Spring Harbor Laboratory. Renowned for pioneering single-cell sequencing innovations-including multiomics, copy-number, methylome, transcriptome, telomere, and multiplexing technologies-he has applied these breakthroughs to major biomedical challenges across cancer, stem cells, organoids, aging, infectious diseases, immunology, brain disorders, and precision medicine. Dr. Pan has authored over 160 publications in high-impact journals such as Nature, PNAS, Advanced Science, Nucleic Acids Research, and Nature Communications, accumulating more than 8,500 citations and an H-index of 40, alongside 15 issued patents in the U.S. and China. His work has been supported by national and international foundations including NSFC, NIH, NSF, MOST, and leading provincial and municipal programs. A dedicated educator who has trained over 60 researchers and taught nearly 10,000 students, he also serves as an Associate Editor of Precision Clinical Medicine and Monocytomics, reviewer for more than 30 top journals, and evaluator for major grant agencies and academic degree committees. As an organizer and keynote speaker at over 100 global conferences, including co-chairing the International Conference on Single Cell and Spatial Omics (TICSSO), Dr. Pan has also held leadership roles in multiple scientific societies and earned numerous accolades such as UICC and CSHL Scholarships, PolyGenomics Fellowship, VEBLEO Fellow, Nanjing Leading Talent, Guangzhou High-Level Talent, Ganpo Distinguished Professor, and the CastUSA Single Cell Genomics Pioneer Award, solidifying his global influence in single-cell biology and precision regenerative medicine.

Profiles: Scopus | Orcid

Featured Publications

"A medium throughput approach for single cell copy number variation sequencing towards efficient application in clinics", Guanchuan Lin; Caiming Chen; Mengchang Xu; Bin Peng; Zhanying Dong; Xuewen Zhou; Jinyu Gao; Jie Yu; Bei Jia; Chen Luo et al., 2025

"Causal effects of immune cell phenotypes on the risk of autoimmune liver diseases: a bidirectional two-sample Mendelian randomization study",Hongjie Zou; Xinghe Liang; Mengqi Luo; Xinghua Pan; De-Ke Jiang., 2025

"Dynamic heterogeneity towards drug resistance in AML cells is primarily driven by epigenomic mechanism unveiled by multi-omics analysis", Yulong Zhang; Yanfang Lu; Liyao Mai; Zebin Wen; Min Dai; Siwen Xu; Xianwei Lin; Yongjian Luo; Yinbin Qiu; Yuting Chen et al., 2025

"Transcriptomics-driven exploration of genetic variation and peptide discovery in the sea anemones Anthopleura midori and Actinia equina",Han Zhang; Xinghua Pan; Chen Weigang., 2025

Qianhui Shang | Cancer Genetics | Best Researcher Award

Published on by Genetics and Genomics

Dr. Qianhui Shang | Cancer Genetics | Best Researcher Award

Sichuan University | China

Author Profile

Scopus

Orcid ID

🌟 Biography of Qianhui Shang, PhD 🌟

📚 EARLY ACADEMIC PURSUITS

Dr. Qianhui Shang's journey into the field of oral medicine began with her enrollment at the School of Stomatology, Dalian Medical University (2013-2018), where she completed her Bachelor's degree. Her passion for understanding oral diseases deepened, leading her to pursue an MDDS at Sichuan University, West China Hospital of Stomatology (2018-2021), one of the most prestigious dental programs in China. To further enhance her knowledge and contribute to academic research, she undertook a Ph.D. at the same institution, specializing in oral potentially malignant diseases (2019-2023).

👩‍⚕️ PROFESSIONAL ENDEAVORS

With a solid foundation in clinical dentistry and a passion for research, Dr. Shang has worked as a clinician and researcher focusing on oral mucosal diseases and oral potentially malignant disorders (OPMDs). Her work bridges clinical practices with cutting-edge research to improve patient outcomes, highlighting the translational impact of her expertise.

🧪 CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER GENETICS

Dr. Shang has contributed extensively to the understanding of:

  1. Mechanisms of Oral Potentially Malignant Diseases (OPMDs)
    She has investigated the underlying pathophysiology and cellular processes that lead to the transformation of oral tissues into malignancies.
  2. Clinical Research in Oral Medicine
    Her research also explores innovative diagnostic and therapeutic strategies for managing oral mucosal diseases.

Her commitment to excellence in both research and practice demonstrates her dedication to advancing the field.

🌍 IMPACT AND INFLUENCE

Dr. Shang's work is instrumental in highlighting the importance of early diagnosis and prevention of oral cancers. Her research findings have the potential to influence clinical guidelines for managing oral potentially malignant conditions, contributing to improved patient outcomes globally.

📖 ACADEMIC CITATIONS

Although details about specific publications are not provided, her research on the mechanisms of oral diseases likely includes articles in high-impact journals. Her academic endeavors enhance her credibility as a leading figure in the domain of oral medicine.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Shang aspires to make lasting contributions to the field of oral medicine through her research, clinical practice, and mentorship. Her future vision involves:

  • Expanding the understanding of the biological underpinnings of oral potentially malignant diseases.
  • Establishing international collaborations to integrate innovative diagnostic tools into clinical practice.
  • Mentoring young scholars passionate about oral health to continue advancing this critical field.

✨ ABOUT DR. QIANHUI SHANG

  • Uygur origin, Xinjiang province.
  • Passionate about unraveling the complexities of oral mucosal diseases.
  • Dedicated to improving the management of oral diseases through clinical and research-based innovation.

📑NOTABLE PUBLICATIONS 

"Hydroxychloroquine is effective in oral lichen planus: A multicenter, randomized, controlled trial" 

  • Authors: Xie, Y. , Xu, H. , Li, C. , Zhou, Y. , Chen, Q. Oral
  • Journal: Diseases
  • Year: 2024

"Humoral immune disorders affect clinical outcomes of oral lichen planus" 

  • Authors: Qing, M. , Yang, D. , Shang, Q. , Xu, H. , Chen, Q.
  • Journal: Oral Diseases
  • Year: 2024

"The clinical implication and translational research of OSCC differentiation" 

  • Authors: Shang, Q. , Jiang, Y. , Wan, Z. , Chen, Q. , Xu, H.
  • Journal: British Journal of Cancer
  • Year: 2024

"Periodontitis and the risk of all-cause and cause-specific mortality among US adults with diabetes: A population-based cohort study" 

  • Authors: Li, W. , Peng, J. , Shang, Q. , Zhao, H. , Xu, H.
  • Journal: Journal of Clinical Periodontology
  • Year: 2024

"Angelicin inhibits cell growth and promotes apoptosis in oral squamous cell carcinoma by negatively regulating DUSP6/cMYC signaling pathway" 

  • Authors: Liu, N. , Li, C. , Shang, Q. , Xie, L. , Chen, Q.
  • Journal: Experimental Cell Research
  • Year: 2023

Sami Nassar | Cancer Genetics and Genomics | Best Researcher Award

Published on by Genetics and Genomics

Dr. Sami Nassar | Cancer Genetics and Genomics | Best Researcher Award

Medical University of South Carolina | United States

Author Profile

Orcid ID

🌟 SAMI I. NASSAR: A DEDICATED JOURNEY IN MEDICINE AND RESEARCH

EARLY ACADEMIC PURSUITS 🎓

Sami I. Nassar began his academic journey at Columbia University, where he majored in Neuroscience and Behavior, graduating Cum Laude in 2019 with an impressive GPA of 3.94/4.00. His academic excellence earned him a place in the Psi Chi International Honor Society in Psychology for his outstanding achievements. This strong foundation in neuroscience laid the groundwork for his future medical career. He is currently pursuing his MD at Wayne State University, School of Medicine, where he is on track to graduate in June 2024, having achieved a Step 2 Score of 258—a testament to his dedication to medical excellence.

PROFESSIONAL ENDEAVORS 👨‍⚕️

Throughout his career, Nassar has actively engaged in clinical and research positions across prestigious institutions. His experience as a Research Fellow at the Medical University of South Carolina since 2024 has enabled him to delve into otolaryngological topics, including vertiginous disorders and suicide risk in head and neck cancer patients. At the Henry Ford Health System and Karmanos Cancer Institute, he contributed to significant research on molecular biomarkers and substance use among cancer patients, helping to push the boundaries of cancer research and patient care. His earlier roles, including work at Generation Next Fertility and Columbia University, demonstrate his practical skills in clinical and laboratory settings, offering a holistic approach to patient care and research. These roles also gave him experience in collaborating with medical professionals and managing clinical trials, which have been integral to his development as a medical researcher.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER GENETICS AND GENOMICS 🔬

Nassar’s research has focused heavily on otolaryngology, head and neck cancer, and HPV-related carcinomas. His work on identifying molecular biomarkers and risk factors in cancer patients, such as those for suicide and substance use, has been groundbreaking. His research not only seeks to understand the molecular foundations of cancer but also aims to improve the quality of life for cancer patients. His investigations into tinnitus and vertiginous disorders add further depth to his research portfolio, contributing to patient outcomes in the field of ear, nose, and throat (ENT) medicine.

IMPACT AND INFLUENCE 🏆

Nassar's research has been widely recognized within the medical community, as seen through numerous awards. His work has been presented at leading conferences, such as the American Head and Neck Society's 11th International Conference, where he won the 3rd place poster award in the Education/Care Delivery category. His earlier recognition by the American Journal of Gastroenterology in 2021 further highlights his ability to contribute to diverse fields of medicine. His influence extends to peer-reviewed academic journals, where his manuscripts and abstracts have garnered attention, solidifying his reputation as a promising researcher.

ACADEMIC CITES 📚

Nassar’s work has been cited in reputable journals, including Cancer Epidemiology, Biomarkers & Prevention, and the American Journal of Gastroenterology. His published work on topics like teduglutide therapy for Short Bowel Syndrome and cancer epidemiology reflects his ability to contribute to high-impact scientific literature. These citations, alongside his ongoing manuscripts on suicide and substance use in cancer patients, illustrate his influence on ongoing medical research.

LEGACY AND FUTURE CONTRIBUTIONS 🌍

As a young and promising researcher, Nassar is poised to make even more significant contributions to the field of medicine. His research on biomarkers and immunochemotherapy for cancer treatment, as well as his ongoing investigation into the psychological aspects of cancer care, will likely have a lasting impact on both academic research and clinical practice. His focus on improving patient quality of life through research on mental health and substance use demonstrates his commitment to a holistic approach to medicine, one that integrates both physical and mental health outcomes. His legacy will undoubtedly include shaping future practices in otolaryngology, head and neck oncology, and biomolecular cancer therapy. With his continued drive and dedication, Nassar’s future contributions to medical science promise to push boundaries and pave the way for innovative treatments and care models.

NOTABLE PUBLICATIONS 📑

"S3030 Safety and Efficacy of Teduglutide Therapy for Management of Short Bowel Syndrome After Intestinal Transplantation" 

  • Authors: Sami I. Nassar; Syed-Mohammed Jafri
  • Journal: American Journal of Gastroenterology
  • Year: 2021

"Abstract C067: Disparities in health literacy in patients with head and neck cancer: Considerations for understanding" 

  • Authors: Aleksandra Vidovich; Amy Williams; Samantha H. Tam; Mary K. Miller; Maria Olex; Sami Nassar; Alex Rodriguez; Eric Adjei Boakye
  • Journal: Cancer Epidemiology, Biomarkers & Prevention
  • Year: 2023

"The Role of ctDNA and Liquid Biopsy in the Diagnosis and Monitoring of Head and Neck Cancer: Towards Precision Medicine"

  • Authors: Sami I. Nassar; Amber Suk; Shaun A. Nguyen, MD; Dauren Adilbay; John Pang; Cherie-Ann Nathan
  • Journal: Cancer
  • Year: 2024